Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Steatohepatitis (NASH)
.
Show all posts
Showing posts with label
Steatohepatitis (NASH)
.
Show all posts
Thursday, March 21, 2019
Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
›
Gilead Sciences, Inc. (Nasdaq: GILD) announced that STELLAR-4, a Phase 3, randomized, double-blind, placebo-controlled study evaluating th...
›
Home
View web version
